Retatrutide

Triple agonist (GIP, GLP-1, glucagon) that enhances metabolic rate and maximizes fat loss potential.

Retatrutide simultaneously activates three key metabolic receptors, producing compounding effects on appetite suppression, insulin sensitivity, and energy expenditure. Available in three research dosages to support a range of experimental protocols.

Purity: ≥98% | Form: Lyophilized Powder | Storage: 2–8°C

⚠️ FOR RESEARCH PURPOSES ONLY. NOT FOR HUMAN CONSUMPTION. Handle by qualified research professionals only.